212例Ⅲ期非小细胞肺癌不同治疗方法临床疗效分析  

The analysis of 212 cases of the stage Ⅲ non-small cell lung cancer with different treatment modality

作　　者：易长生[1] 江啸音[1] 黄义文[1] 

机构地区：[1]湖南省肿瘤医院放疗科,湖南长沙410013

出　　处：《现代肿瘤医学》2007年第2期198-199,共2页Journal of Modern Oncology

摘　　要：目的探讨Ⅲ期非小细胞肺癌的不同治疗方法及疗效,寻找较好的治疗方案。方法回顾性分析1997年3月至2001年3月在我院首程治疗的Ⅲ期非小细胞肺癌212例。分手术治疗、放疗和化疗为主组三组进行疗效比较。结果1、3、5年存活率分别为41.9%(89/212)、11.3%(24/212)和6.6%(14/212)。5年存活率手术为主组(A组)为10.3%(6/58),放疗为主组(B组)为5.8%(6/102),化疗为主组(C组)3.8%(2/52)。但无显著性差异。结论Ⅲ期非小细胞肺癌手术治疗为主组比放、化疗为主组的疗效明显。Objective： To analyze the treatment results of the stage Ⅲ non -small cell lung cancer patients with different treatment modality. Methods：To analyze retrospectively 212 stage Ⅲ non -small cell lung cancer patients initially treated in the Hunan Province Tumor Hospital from March, 1997 to March,2001. Results ：The survival rate of 1,3,5 years for the suargery,rachiation,chenotherapy groups were 41.9% （89/212）, 11.3% （24/212） and 6.6% （14/212） respectively. The five year survival rate were 10.3% （6/58） .5.8% （6/102） and 3.8% （2/52） for the patients with the first choice of treatment as surgery, radiotherapy and chemotherapy respectively. The difference among them was statically not siynificant. Conclusion ： The surgery as the initial choice of treatment for the stage Ⅲ non -small cell lung cancer is better than the radiotherapy or chemotherapy.

关 键 词：Ⅲ期非小细胞肺癌 治疗方法 疗效 

分 类 号：R734.2[医药卫生—肿瘤]